Inside Roswell Park’s GMP Cell Manufacturing Facility: Advancing Cell and Gene Therapy

3 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
Check out the full article here: https://oncdata.com/roswell-park-gmp-engineering-and-cell-manufacturing-facility

0:00 Introduction
2:40 GMP Cell Manufacturing Facility
3:50 New Equipment and Expansion
5:05 Advancing Therapeutic Development
6:30 Funding and Cost Effectiveness
8:07 Future and Ongoing Research
9:40 Improving Cancer Care Delivery

Explore the groundbreaking advancements in cell and gene therapy at Roswell Park Comprehensive Cancer Center’s newly expanded Good Manufacturing Practices (GMP) Engineering and Cell Manufacturing Facility (GEM). Now the largest academic GMP facility in the U.S., this state-of-the-art center is revolutionizing the development and delivery of CAR T-cell therapies, engineered T-cell receptor (TCR) treatments, and dendritic cell vaccines.

In this interview, Dr. Christopher Choi, Technical Director of the GMP Facility, shares insights into how this cutting-edge facility is overcoming manufacturing bottlenecks, streamlining regulatory compliance, and accelerating the transition of novel therapies from research to clinical application. Learn how this expansion is making advanced cancer treatments more accessible and why it represents a major leap forward in personalized medicine.

Watch now to gain expert insights into the future of cell and gene therapy.

#CellTherapy #GeneTherapy #GMPManufacturing #CART #CancerResearch #OncologyInnovation #MedicalBreakthrough #RoswellPark #Hematology #Immunotherapy
Category
Oncology
Be the first to comment

Up Next